Skeletal metabolism: Long-term administration in animal models has been associated with an increase in bone mineral content, suggesting that elevated GH levels may support bone homeostasis and tissue remodeling
The REDEFINE 1 trial found that when evaluating the treatment effect regardless of whether patients stayed on treatment, those treated with CagriSema achieved weight loss of 20.4% (from an average baseline body weight of 236 lb) at 68 weeks versus 3.0% (from an average baseline body weight of 235 lb) for the placebo group which was statistically significant
Five subjects in treatment arm 2 h30 min and eight subjects in treatment arm 2 hnight had no quantifiable exposure to semaglutide
Wang D, Feng Y, Liu J, Yan J, Wang M, Sasaki JI, et al
Pablo de la Cueva ha participado como asesor y/o investigador y/o ponente con los siguientes laboratorios farmacuticos: Abbvie, Almirall, BMS, Boehringer-Ingelheim, Celgene, Janssen Cilag, LEO Pharma, Lilly, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi y UCB
The 2006 human study that Protandim quoted above is only a half-truth: yes, there was a 40% decrease in oxidative stress in study subjects using the TBARS test (which is not considered to be a reliable marker.) The methodology was also a mess